MicroRNA-124 regulates STAT3 expression and is down-regulated in colon tissues of pediatric patients with ulcerative colitis

Gastroenterology

Volumn 145, Issue 4, 2013, Pages

  Koukos, Georgios ^a,b   Polytarchou, Christos ^a,b   Kaplan, Jess L ^c   Morley Fletcher, Alessio ^c   Gras Miralles, Beatriz ^d   Kokkotou, Efi ^d   Baril Dore, Mariah ^c   Pothoulakis, Charalabos ^a   Winter, Harland S ^c   Iliopoulos, Dimitrios ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

IL6 BCLXL Let 7 Gene Regulation

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; GELATINASE B; INTERLEUKIN 6; MICRORNA; MICRORNA 101; MICRORNA 124; MICRORNA 125; MICRORNA 26; PROTEIN; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN LET 7; STAT3 PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

3' UNTRANSLATED REGION; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; COLON BIOPSY; COLON MUCOSA; CONTROLLED STUDY; DNA METHYLATION; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; TRANSCRIPTION INITIATION; ULCERATIVE COLITIS;

EID: 84884373262     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2013.07.001     Document Type: Article

References (44)

1. J. Scholmerich New developments in aetiological mechanisms of inflammatory bowel disease Eur J Gastroenterol Hepatol 15 2003 585 586
2. B. Khor, A. Gardet, and R.J. Xavier Genetics and pathogenesis of inflammatory bowel disease Nature 474 2011 307 317
3. S. Danese, and C. Fiocchi Ulcerative colitis N Engl J Med 365 2011 1713 1725
4. L. Jostins, S. Ripke, and R.K. Weersma Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease Nature 491 2012 119 124
5. A. Bousvaros, F. Sylvester, and S. Kugathasan Challenges in pediatric inflammatory bowel disease Inflamm Bowel Dis 12 2006 885 913
6. K. Sugimoto Role of STAT3 in inflammatory bowel disease World J Gastroenterol 14 2008 5110 5114
7. A. Musso, P. Dentelli, and A. Carlino Signal transducers and activators of transcription 3 signaling pathway: an essential mediator of inflammatory bowel disease and other forms of intestinal inflammation Inflamm Bowel Dis 11 2005 91 98
8. R. Atreya, and M.F. Neurath Involvement of IL-6 in the pathogenesis of inflammatory bowel disease and colon cancer Clin Rev Allergy Immunol 28 2005 187 196
9. T.A. Willson, B.R. Kuhn, and I. Jurickova STAT3 genotypic variation and cellular STAT3 activation and colon leukocyte recruitment in pediatric Crohn disease J Pediatr Gastroenterol Nutr 55 2012 32 43
10. D.P. Bartel MicroRNAs: target recognition and regulatory functions Cell 136 2009 215 233
11. M. Hatziapostolou, C. Polytarchou, and E. Aggelidou An HNF4alpha-miRNA inflammatory feedback circuit regulates hepatocellular oncogenesis Cell 147 2011 1233 1247
12. E. Stagakis, G. Bertsias, and P. Verginis Identification of novel microRNA signatures linked to human lupus disease activity and pathogenesis: miR-21 regulates aberrant T cell responses through regulation of PDCD4 expression Ann Rheum Dis 70 2011 1496 1506
13. C. Du, C. Liu, and J. Kang MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis Nat Immunol 10 2009 1252 1259
14. K.M. Smith, M. Guerau-de-Arellano, and S. Costinean miR-29ab1 deficiency identifies a negative feedback loop controlling Th1 bias that is dysregulated in multiple sclerosis J Immunol 189 2012 1567 1576
15. A. Androulidaki, D. Iliopoulos, and A. Arranz The kinase Akt1 controls macrophage response to lipopolysaccharide by regulating microRNAs Immunity 31 2009 220 231
16. D. Iliopoulos, S.A. Jaeger, and H.A. Hirsch STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer Mol Cell 39 2010 493 506
17. S.R. Dalal, and J.H. Kwon The Role of MicroRNA in Inflammatory Bowel Disease Gastroenterol Hepatol (N Y) 6 2010 714 722
18. F. Wu, M. Zikusoka, and A. Trindade MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha Gastroenterology 135 2008 1624 1635.e24
19. F. Wu, S. Zhang, and T. Dassopoulos Identification of microRNAs associated with ileal and colonic Crohn's disease Inflamm Bowel Dis 16 2010 1729 1738
20. F. Wu, N.J. Guo, and H. Tian Peripheral blood microRNAs distinguish active ulcerative colitis and Crohn's disease Inflamm Bowel Dis 17 2011 241 250
21. A. Paraskevi, G. Theodoropoulos, and I. Papaconstantinou Circulating MicroRNA in inflammatory bowel disease J Crohns Colitis 6 2012 900 904
22. H.W. Koon, D. Zhao, and Y. Zhan Substance P mediates antiapoptotic responses in human colonocytes by Akt activation Proc Natl Acad Sci U S A 104 2007 2013 2018
23. D.J. Berg, J. Zhang, and J.V. Weinstock Rapid development of colitis in NSAID-treated IL-10-deficient mice Gastroenterology 123 2002 1527 1542
24. S.M. Wilting, R.A. van Boerdonk, and F.E. Henken Methylation-mediated silencing and tumour suppressive function of hsa-miR-124 in cervical cancer Mol Cancer 9 2010 167
25. J.V. Alvarez, and D.A. Frank Genome-wide analysis of STAT target genes: elucidating the mechanism of STAT-mediated oncogenesis Cancer Biol Ther 3 2004 1045 1050
26. D. Iliopoulos, H.A. Hirsch, and K. Struhl An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation Cell 139 2009 693 706
27. A. Lujambio, S. Ropero, and E. Ballestar Genetic unmasking of an epigenetically silenced microRNA in human cancer cells Cancer Res 67 2007 1424 1429
28. S. Danese, M. Sans, and C. de la Motte Angiogenesis as a novel component of inflammatory bowel disease pathogenesis Gastroenterology 130 2006 2060 2073
29. D.G. Karamanolis, I. Kyrlagkitsis, and K. Konstantinou The Bcl-2/Bax system and apoptosis in ulcerative colitis Hepatogastroenterology 54 2007 1085 1088
30. M.A. Manfredi, D. Zurakowski, and P.A. Rufo Increased incidence of urinary matrix metalloproteinases as predictors of disease in pediatric patients with inflammatory bowel disease Inflamm Bowel Dis 14 2008 1091 1096
31. M.J. Meijer, M.A. Mieremet-Ooms, and A.M. van der Zon Increased mucosal matrix metalloproteinase-1, -2, -3 and -9 activity in patients with inflammatory bowel disease and the relation with Crohn's disease phenotype Dig Liver Dis 39 2007 733 739
32. S.W. Kim, K. Ramasamy, and H. Bouamar MicroRNAs miR-125a and miR-125b constitutively activate the NF-kappaB pathway by targeting the tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20) Proc Natl Acad Sci U S A 109 2012 7865 7870
33. E. Surdziel, M. Cabanski, and I. Dallmann Enforced expression of miR-125b affects myelopoiesis by targeting multiple signaling pathways Blood 117 2011 4338 4348
34. Y. Hayashi, M. Tsujii, and J. Wang CagA mediates epigenetic regulation to attenuate let-7 expression in Helicobacter pylori-related carcinogenesis Gut 2012 Sep 23. [Epub ahead of print]
35. J. Lu, M.L. He, and L. Wang MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2 Cancer Res 71 2011 225 233
36. J. Gao, and Q.G. Liu The role of miR-26 in tumors and normal tissues (Review) Oncol Lett 2 2011 1019 1023
37. K.A. Padgett, R.Y. Lan, and P.C. Leung Primary biliary cirrhosis is associated with altered hepatic microRNA expression J Autoimmun 32 2009 246 253
38. J. Zhang, C. Han, and T. Wu MicroRNA-26a promotes cholangiocarcinoma growth by activating beta-catenin Gastroenterology 143 2012 246 256 e8
39. P. Cao, Z. Deng, and M. Wan MicroRNA-101 negatively regulates Ezh2 and its expression is modulated by androgen receptor and HIF-1alpha/HIF-1beta Mol Cancer 9 2010 108
40. Z. Lin, J.P. Hegarty, and W. Yu Identification of disease-associated DNA methylation in B cells from Crohn's disease and ulcerative colitis patients Dig Dis Sci 57 2012 3145 3153
41. Z. Lin, J.P. Hegarty, and J.A. Cappel Identification of disease-associated DNA methylation in intestinal tissues from patients with inflammatory bowel disease Clin Genet 80 2011 59 67
42. R. Kellermayer Epigenetics and the developmental origins of inflammatory bowel diseases Can J Gastroenterol 26 2012 909 915
43. M. Furuta, K.I. Kozaki, and S. Tanaka miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma Carcinogenesis 31 2010 766 776
44. T. Ando, T. Yoshida, and S. Enomoto DNA methylation of microRNA genes in gastric mucosae of gastric cancer patients: its possible involvement in the formation of epigenetic field defect Int J Cancer 124 2009 2367 2374